Dr. Khasraw’s research interests include biomarker development and design of innovative clinical trials to improve outcomes for patients with primary and metastatic cancers of the central nervous systems. He is a Neuro-oncologist, professor of medicine and Deputy Director of the Center for Cancer Immunotherapy at Duke University, USA. He is interested in translating research into new therapies. At Duke, he is tasked with speeding up clinical research and translation for scientists across all departments and tumor sites.
Dr. Khasraw is leading several clinical and translational programs with significant laboratory collaborations and is the principal investigator on first-in-human Phase I immunotherapy clinical trials in solid tumors. He serves as an advisor and grant reviewer for several non-profits and patient advocacy groups. He is a Fellow of the Royal Australasian College of Physicians and an Elected Fellow of the Royal College of Physicians (UK) and an Honorary Professor at the University of Sydney (Australia).
